523 related articles for article (PubMed ID: 21619430)
1. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
[TBL] [Abstract][Full Text] [Related]
2. Clinically relevant cancer biomarkers and pharmacogenetic assays.
Patel JN; Mandock K; McLeod HL
J Oncol Pharm Pract; 2014 Feb; 20(1):65-72. PubMed ID: 23353710
[TBL] [Abstract][Full Text] [Related]
3. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
4. Towards a global IT system for personalized medicine: the Medicine Safety Code initiative.
Samwald M; Minarro-Giménez JA; Blagec K; Adlassnig KP
Stud Health Technol Inform; 2014; 205():261-5. PubMed ID: 25160186
[TBL] [Abstract][Full Text] [Related]
5. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
6. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
Mladosievicova B; Carter A; Kristova V
Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
[TBL] [Abstract][Full Text] [Related]
7. Stakeholder views on pharmacogenomic testing.
Patel HN; Ursan ID; Zueger PM; Cavallari LH; Pickard AS
Pharmacotherapy; 2014 Feb; 34(2):151-65. PubMed ID: 24167008
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic application in personalized cancer treatment.
Kristyanto H; Utomo AR
Acta Med Indones; 2010 Apr; 42(2):109-15. PubMed ID: 20513938
[TBL] [Abstract][Full Text] [Related]
9. Can pharmacogenetics help rescue drugs withdrawn from the market?
Shah RR
Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of cancer drugs.
Hertz DL; Rae J
Annu Rev Med; 2015; 66():65-81. PubMed ID: 25386932
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic biomarkers for personalized medicine.
Chen JJ; Lin WJ; Chen HC
Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
[TBL] [Abstract][Full Text] [Related]
12. Application of genotype-guided cancer therapy in solid tumors.
Patel JN
Pharmacogenomics; 2014 Jan; 15(1):79-93. PubMed ID: 24329193
[TBL] [Abstract][Full Text] [Related]
13. One size fits one: pharmacogenetics in gastroenterology.
Porayette P; Flockhart D; Gupta SK
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
[TBL] [Abstract][Full Text] [Related]
14. Individualized drug therapy.
Daly AK
Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
[TBL] [Abstract][Full Text] [Related]
16. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
Shimazawa R; Ikeda M
J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.
Elie V; de Beaumais T; Fakhoury M; Jacqz-Aigrain E
Pharmacogenomics; 2011 Jun; 12(6):827-43. PubMed ID: 21692614
[TBL] [Abstract][Full Text] [Related]
18. Towards a global IT system for personalized medicine: the Medicine Safety Code initiative.
Samwald M; Minarro-Giménez JA; Blagec K; Adlassnig KP
Stud Health Technol Inform; 2014; 198():25-31. PubMed ID: 24825681
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic procedures for paraffin-embedded tissues analysis in pharmacogenomic studies.
Palmirotta R; De Marchis ML; Ludovici G; Ferroni P; Abete P; Guadagni F; Della-Morte D
Methods Mol Biol; 2014; 1175():45-65. PubMed ID: 25150866
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
Low SK; Takahashi A; Mushiroda T; Kubo M
Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]